adult gliosarcoma
Showing 26 - 50 of >10,000
Glioblastoma, Gliosarcoma Trial in Houston (drug, radiation, procedure)
Recruiting
- Glioblastoma
- Gliosarcoma
- Nedisertib
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Sep 27, 2022
Adult Ependymoblastoma, Adult Giant Cell Glioblastoma, Adult Glioblastoma Trial in Stanford (radiation, drug, other)
Completed
- Adult Ependymoblastoma
- +8 more
- radiation therapy
- +4 more
-
Stanford, CaliforniaStanford University, School of Medicine
Sep 27, 2018
Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma Trial in United States (FMISO, MRI, PET)
Completed
- Adult Giant Cell Glioblastoma
- +2 more
- FMISO
- +3 more
-
Birmingham, Alabama
- +13 more
Mar 14, 2019
Glioblastoma, Gliosarcoma Trial in Miami, Atlanta, Baltimore (radiation, procedure, drug)
Active, not recruiting
- Glioblastoma
- Gliosarcoma
- Dose-Escalated Radiation Therapy
- +2 more
-
Miami, Florida
- +2 more
Feb 16, 2022
Brain and CNS Tumors Trial in Cleveland (aminolevulinic acid, Surgical Resection)
Completed
- Brain and Central Nervous System Tumors
- aminolevulinic acid
- Surgical Resection
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Sep 13, 2021
Glioblastoma Multiforme of Brain, Anaplastic Astrocytoma of Brain, Gliosarcoma of Brain Trial in Birmingham (C134)
Active, not recruiting
- Glioblastoma Multiforme of Brain
- +2 more
- C134
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Sep 19, 2022
Malignant Glioma, Glioblastoma, Gliosarcoma Trial in Durham (Bevacizumab, Temozolomide, Radiation Therapy (XRT))
Completed
- Malignant Glioma
- +2 more
- Bevacizumab
- +3 more
-
Durham, North CarolinaThe Preston Robert Tisch Brain Tumor Center at Duke
Mar 29, 2022
Brain and CNS Tumors Trial in Los Angeles (biological, drug, radiation)
Completed
- Brain and Central Nervous System Tumors
- bevacizumab
- +2 more
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center, University of California, L
Aug 31, 2020
Brain Tumors, Metastatic Disease Trial in United States (donepezil HCl, Placebo)
Completed
- Brain Tumors
- Metastatic Disease
- donepezil hydrochloride
- Placebo
-
Wichita, Kansas
- +15 more
Sep 27, 2021
Glioblastoma, Adult Trial in Cleveland (Pembrolizumab at 7 days prior, Pembrolizumab at 14 days post, Pembrolizumab at 35 days
Recruiting
- Glioblastoma, Adult
- Pembrolizumab at 7 days prior
- +3 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 17, 2023
Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma Trial in Cleveland (aminolevulinic acid, therapeutic
Terminated
- Adult Giant Cell Glioblastoma
- +3 more
- aminolevulinic acid
- therapeutic conventional surgery
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jul 5, 2018
Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Atlanta (Liothyronine, Lomustine, Methimazole)
Recruiting
- Recurrent Glioblastoma
- Recurrent Gliosarcoma
- Liothyronine
- +2 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Feb 23, 2022
Brain and CNS Tumors Trial in Los Angeles (bortezomib + temozolomide+ radiation therapy)
Completed
- Brain and Central Nervous System Tumors
- bortezomib + temozolomide+ radiation therapy
-
Los Angeles, CaliforniaUniversity of California Los Angeles
Aug 26, 2020
Glioblastoma, Gliosarcoma, Malignant Glioma Trial run by the NCI (TMZ, ipilimumab 3mg/kg, Nivolumab)
Recruiting
- Glioblastoma
- +2 more
- TMZ
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 31, 2023
Brain Tumors, Nervous System Tumors, Cognition Disorders Trial in Winston-Salem (Armodafinil, )
Completed
- Brain Tumors
- +3 more
- Armodafinil
- placebo
-
Winston-Salem, North CarolinaWake Forest University Comprehensive Cancer Center
Sep 7, 2021
Gliosarcoma, Recurrent Glioblastoma Trial in Chicago (Laboratory Biomarker Analysis, Pharmacological Study, Targeted Molecular
Completed
- Gliosarcoma
- Recurrent Glioblastoma
- Laboratory Biomarker Analysis
- +2 more
-
Chicago, IllinoisNorthwestern University
Aug 5, 2022
Brain Tumor, Astrocytoma, Astroglioma Trial run by the NCI (Zotiraciclib (TG02), Temozolomide (TMZ))
Completed
- Brain Tumor
- +4 more
- Zotiraciclib (TG02)
- Temozolomide (TMZ)
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Sep 3, 2021
Glioblastoma Multiforme Trial in Australia, United States (Nivolumab, Temozolomide)
Active, not recruiting
- Glioblastoma Multiforme
-
Durham, North Carolina
- +19 more
Jul 14, 2022
Malignant Tumors Brain Trial in Durham (RNA-loaded dendritic cell vaccine, basiliximab)
Completed
- Malignant Neoplasms Brain
- RNA-loaded dendritic cell vaccine
- basiliximab
-
Durham, North CarolinaDuke University Medical Center
Mar 8, 2021
Pediatric Solid Tumor, Pediatric Lymphoma, Pediatric Brain Tumor Trial in Australia, Canada, United States (CLR 131)
Recruiting
- Pediatric Solid Tumor
- +7 more
- CLR 131
-
Palo Alto, California
- +6 more
Nov 30, 2021
Brain Cancer, Brain Tumor, Glioma Trial in Canada, United States (DNX-2401, pembrolizumab)
Completed
- Brain Cancer
- +10 more
- DNX-2401
- pembrolizumab
-
Little Rock, Arkansas
- +14 more
Jul 13, 2021
Brain and CNS Tumors Trial in United States (biological, device, radiation)
Terminated
- Brain and Central Nervous System Tumors
- bleomycin
- +2 more
-
Phoenix, Arizona
- +12 more
Oct 21, 2020
Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Meningioma Trial in Winston-Salem (yoga therapy,
Terminated
- Adult Anaplastic Astrocytoma
- +22 more
- yoga therapy
- +2 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Jul 2, 2018
Brain and CNS Tumors Trial in Los Angeles (Erlotinib + Sirolimus)
Completed
- Brain and Central Nervous System Tumors
- Erlotinib + Sirolimus
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center at UCLA
Jul 29, 2020
Undergoing Stereotactic Radiosurgery for Brain Tumors or Other
Completed
- Brain and Central Nervous System Tumors
- +2 more
- Questionnaire
-
Cleveland, OhioCleveland Clinic Taussig Cancer Center
Jul 23, 2020